Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 3Colorectal Neoplasms 2Breast Diseases 2Thrombocythemia, Essential 1Polycythemia Vera 1Lymphedema 1Liver Neoplasms 1Hypogonadism 1Glioma 1Fatigue Syndrome, Chronic 1Eunuchism 1Adenoma 1

Interventions

Oxaliplatin 270Bevacizumab 260Fluorouracil 249Irinotecan 240Leucovorin 218Capecitabine 196Cetuximab 161Colonoscopy 74Folfox protocol 70Panitumumab 64regorafenib 62Drug Therapy 52Radiotherapy 50HMPL-013 50Blood Specimen Collection 45trifluridine tipiracil drug combination 43pembrolizumab 41Surveys and Questionnaires 35Standard of Care 35Nivolumab 34Neoadjuvant Therapy 34Surgical Procedures, Operative 33Magnetic Resonance Spectroscopy 31IFL protocol 27Trifluridine 26Interviews as Topic 26Celecoxib 26XELOX 25Early Intervention, Educational 24Specimen Handling 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Colorectal Neoplasms × Drug Evaluation × Clear all
NCT05883683 2024-07-24

MSPM

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Not yet recruiting
100 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00582660 2017-06-15

UAB0040

University of Alabama at Birmingham

Phase 2 Completed
40 enrolled 7 charts
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡